CoMind

CoMind is a London-based neurotechnology company founded in 2018 by James Dacombe.

The company specializes in non-invasive neurosensing platforms designed to monitor and assess brain health in various healthcare settings, including neuroscience, neurology, and intensive care. CoMind's mission is to enhance patient outcomes by providing clinicians with real-time neurophysiological signals that were previously difficult to access. The flagship product, CoMind One, is a non-invasive brain monitoring system that uses an adhesive sensor placed on the forehead. It employs low-powered infrared lasers to capture data on cerebral perfusion, autoregulation, and intracranial pressure without the need for invasive procedures. This technology aims to improve monitoring accuracy and reduce complications associated with traditional methods. CoMind has raised over $162.5 million in funding and is currently advancing toward regulatory approval, with ongoing clinical trials in multiple locations.